Emerging markets are a big opportunity for pharma companies. But from the R&D productivity standpoint, these markets create new challenges in genomic complexity. So, in research and clinic development process, trials need to be more inclusive taking into context the wider population that the companies will have to deal with..
Pharmaceutical Industry White Papers
'White Papers' is specialized section provide real, actionable information to prospects. Done well, they shorten sales cycles, educate prospects and showcase a company’s thought leadership. White papers are hosted behind a registration-based landing page that captures key lead scoring information.
White Paper publication program on pharmatechglobal.net benefit from our integrated audience database. Registration can be pre-populated based on our database of professionals, providing for superior conversion rates. — If interested, Post your company's White Papers here
Aerogen’s vibrating mesh nebuliser technology, available within the Aerogen® Solo, Pro and also the NIVO, has been adopted for use across many areas of the hospital during a variety of ventilatory support including conventional mechanical ventilation, high frequency oscillatory ventilation, noninvasive ventilation and nasal high flow.
modum.io sensor devices record environmental conditions while physical products are in transit. When a change in ownership occurs, the collected data is checked against a specific smart contract in the blockchain.
The big question in pharma is: where does this disruption stand and where is it heading? That was the main topic of conversation during the Digital Health’s Disruption of Pharma panel discussion at the recent mHealth Summit.
Packaging standards are growing in complexity as manufacturers serve an increasingly global customer base, and serialization requirements continue to be deployed across a number of countries.